Bluesky Facebook Reddit Email

Noncancerous chest CT features for predicting survival in stage I lung cancer

04.13.22 | American Roentgen Ray Society

Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.


Leesburg, VA, April 13, 2022 According to ARRS’ American Journal of Roentgenology ( AJR ) , noncancerous imaging markers on chest CT performed before stereotactic body radiation therapy (SBRT) improve survival prediction, compared with clinical features alone.

“In patients undergoing SBRT for stage I lung cancer,” explained corresponding author and 2019 ARRS Scholar Florian J. Fintelmann , “higher coronary artery calcium (CAC) score, higher pulmonary artery (PA)-to-aorta ratio, and lower thoracic skeletal muscle index independently predicted worse overall survival.”

Fintelmann and team’s retrospective study included 282 patients (168 female, 114 male; median age, 75 years) with stage I lung cancer treated with SBRT between January 2009 and June 2017. To quantify CAC score and PA-to-aorta ratio, as well as emphysema and body composition, pretreatment chest CT was used. Associations of clinical and imaging features with overall were quantified using a multivariable Cox proportional hazards (PH) model.

For stage I lung cancer patients treated with SBRT, CAC score, PA-to-aorta ratio, and skeletal muscle index showed significant independent associations with overall survival. (p<.05). The model including clinical and imaging features demonstrated better discriminatory ability for 5-year overall survival than the model including clinical features alone (AUC 0.75 vs. 0.61, p<.01).

“The PA-to-aorta ratio, which is readily quantifiable with electronic calipers during routine image review, was the most important predictor of overall survival,” the authors of this AJR article concluded .

An electronic supplement to this AJR article is available here .

North America’s first radiological society, the American Roentgen Ray Society (ARRS) remains dedicated to the advancement of medicine through the profession of medical imaging and its allied sciences. An international forum for progress in radiology since the discovery of the x-ray, ARRS maintains its mission of improving health through a community committed to advancing knowledge and skills with the world’s longest continuously published radiology journal— American Journal of Roentgenology —the ARRS Annual Meeting, InPractice magazine, topical symposia, myriad multimedia educational materials, as well as awarding scholarships via The Roentgen Fund ®.

MEDIA CONTACT :

Logan K. Young, PIO

44211 Slatestone Court

Leesburg, VA 20176

703-858-4332

lyoung@arrs.org

American Journal of Roentgenology

10.2214/AJR.22.27484

Observational study

People

Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy

13-Apr-2022

Dr. Fintelmann received salary support from the American Roentgen Ray Society during the study period.

Keywords

Article Information

Contact Information

Logan Young
American Roentgen Ray Society
lyoung@arrs.org

Source

How to Cite This Article

APA:
American Roentgen Ray Society. (2022, April 13). Noncancerous chest CT features for predicting survival in stage I lung cancer. Brightsurf News. https://www.brightsurf.com/news/8Y4J3RZL/noncancerous-chest-ct-features-for-predicting-survival-in-stage-i-lung-cancer.html
MLA:
"Noncancerous chest CT features for predicting survival in stage I lung cancer." Brightsurf News, Apr. 13 2022, https://www.brightsurf.com/news/8Y4J3RZL/noncancerous-chest-ct-features-for-predicting-survival-in-stage-i-lung-cancer.html.